Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Better Therapeutics Inc.

    OTC: BTTX · Real-Time Price · USD
    0.00
    -0.00 (-100.00%)
    At close: Mar 31, 2025, 3:22 PM

    Better Therapeutics Statistics

    Share Statistics

    Better Therapeutics has 54.52M shares outstanding. The number of shares has increased by 0% in one year.

    Shares Outstanding

    n/a
    		 54.52M

    Shares Change (YoY)

    n/a
    		 0%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 0.01%

    Shares Floating

    n/a
    		 25.69M

    Failed to Deliver (FTD) Shares

    n/a
    		 n/a

    FTD / Avg. Volume

    n/a
    		 n/a

    Short Selling Information

    The latest short interest is 2.13M, so undefined% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 2.13M

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 8.68%

    Short Ratio (days to cover)

    n/a
    		 0.94

    Valuation Ratios

    The PE ratio is -0.66 and the forward PE ratio is null. Better Therapeutics's PEG ratio is 0.56.

    PE Ratio

    n/a
    		 -0.66

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 -29.09

    P/FCF Ratio

    n/a
    		 -0.87

    PEG Ratio

    n/a
    		 0.56
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Better Therapeutics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 1.37, with a Debt / Equity ratio of -16.55.

    Current Ratio

    n/a
    		 1.37

    Quick Ratio

    n/a
    		 1.37

    Debt / Equity

    n/a
    		 -16.55

    Debt / EBITDA

    n/a
    		 -0.39

    Debt / FCF

    n/a
    		 -0.49

    Interest Coverage

    n/a
    		 -25.66

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-736,296.3

    Employee Count

    n/a
    		 54

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 7K

    Effective Tax Rate

    n/a
    		 -0.02%

    Stock Price Statistics

    The stock price has increased by null% in the last 52 weeks. The beta is 1.69, so Better Therapeutics's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.69

    52-Week Price Change

    n/a
    		 n/a

    50-Day Moving Average

    n/a
    		 0

    200-Day Moving Average

    n/a
    		 0

    Relative Strength Index (RSI)

    n/a
    		 63.59

    Average Volume (20 Days)

    n/a
    		 n/a

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 -2.73M

    Operating Income

    n/a
    		 -38.26M

    Net Income

    n/a
    		 -39.76M

    EBITDA

    n/a
    		 -38.26M

    EBIT

    n/a
    		 n/a

    Earnings Per Share (EPS)

    n/a
    		 -1.69
    Full Income Statement

    Balance Sheet

    The company has 15.74M in cash and 14.88M in debt, giving a net cash position of 860K.

    Cash & Cash Equivalents

    n/a
    		 15.74M

    Total Debt

    n/a
    		 14.88M

    Net Cash

    n/a
    		 860K

    Retained Earnings

    n/a
    		 -111.5M

    Total Assets

    n/a
    		 10.72M

    Working Capital

    n/a
    		 -5.59M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -28.93M and capital expenditures -1.18M, giving a free cash flow of -30.11M.

    Operating Cash Flow

    n/a
    		 -28.93M

    Capital Expenditures

    n/a
    		 -1.18M

    Free Cash Flow

    n/a
    		 -30.11M

    FCF Per Share

    n/a
    		 -1.28
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    BTTX does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for BTTX.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -27.28

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist